{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:56:12Z","timestamp":1792133772304,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":1339,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/jth.14160","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T09:36:06Z","timestamp":1527672966000},"page":"1498-1509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Hemorrhagic disorders of fibrinolysis: a clinical review"],"prefix":"10.1016","volume":"16","author":[{"given":"J.L.","family":"Saes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.M.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Nijziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14160_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman\u2010Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","article-title":"Elements of the fibrinolytic system","volume":"936","author":"Lijnen","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/jth.14160_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","article-title":"New insights into the molecular mechanisms of the fibrinolytic system","volume":"7","author":"Rijken","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1538-7836.2010.03787.x","article-title":"What has been learnt from the thrombin\u2010activatable fibrinolysis inhibitor\u2010deficient mouse?","volume":"8","author":"Morser","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild\u2010to\u2010moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1111\/jth.14160_bb0035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0037-1616530","article-title":"The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0040","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jth.13342","article-title":"Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin\u2010independent impairment of the thrombin\u2010activatable fibrinolysis inhibitor pathway","volume":"14","author":"Colucci","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.thromres.2011.12.006","article-title":"Global haemostasis assays, from bench to bedside","volume":"129","author":"van Geffen","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0050","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"Ilich","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.14160_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI\u20101","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1538-7836.2007.02816.x","article-title":"Development of a new test for the global fibrinolytic capacity in whole blood","volume":"6","author":"Rijken","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2001.02845.x","article-title":"Congenital alpha(2)\u2010plasmin inhibitor deficiencies: a review","volume":"114","author":"Favier","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0070","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-2516.2008.01766.x","article-title":"Alpha2\u2010antiplasmin and its deficiency: fibrinolysis out of balance","volume":"14","author":"Carpenter","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0888-7543(92)90224-G","article-title":"Assignment of the human alpha 2\u2010plasmin inhibitor gene (PLI) to chromosome 17, region pter\u2010p12, by PCR analysis of somatic cell hybrids","volume":"13","author":"Welch","year":"1992","journal-title":"Genomics"},{"key":"10.1111\/jth.14160_bb0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0140-6736(78)91973-6","article-title":"Alpha2\u2010plasmin\u2010inhibitor deficiency (Miyasato disease)","volume":"2","author":"Koie","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/jth.14160_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0140-6736(79)91481-8","article-title":"Homozygous alpha 2\u2010antiplasmin deficiency","volume":"2","author":"Kluft","year":"1979","journal-title":"Lancet"},{"key":"10.1111\/jth.14160_bb0090","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V59.6.1246.1246","article-title":"A bleeding disorder due to deficiency of alpha 2\u2010antiplasmin","volume":"59","author":"Miles","year":"1982","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.38.4.428","article-title":"A bleeding disorder due to deficiency of alpha 2\u2010antiplasmin","volume":"38","author":"Kettle","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.14160_bb0100","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI113217","article-title":"alpha 2\u2010Antiplasmin Enschede: dysfunctional alpha 2\u2010antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder","volume":"80","author":"Kluft","year":"1987","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14160_bb0105","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1213\/00000539-199705000-00038","article-title":"Severe postadenoidectomy bleeding revealing congenital alpha 2 antiplasmin deficiency in a child","volume":"84","author":"Paqueron","year":"1997","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14160_bb0110","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s002470050513","article-title":"A case of intramedullary haematoma associated with congenital alpha2\u2010plasmin inhibitor deficiency","volume":"28","author":"Devaussuzenet","year":"1998","journal-title":"Pediatr Radiol"},{"key":"10.1111\/jth.14160_bb0115","first-page":"321","article-title":"Intramedullary multiple hematomas in siblings with congenital alpha\u20102\u2010plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid","volume":"21","author":"Takahashi","year":"1991","journal-title":"Haemostasis"},{"key":"10.1111\/jth.14160_bb0120","first-page":"176","article-title":"Congenital deficiency of alpha 2\u2010plasmin inhibitor in three sisters","volume":"11","author":"Yoshioka","year":"1982","journal-title":"Haemostasis"},{"key":"10.1111\/jth.14160_bb0125","first-page":"28","article-title":"[A homozygous quantitative defect of alpha 2\u2010antiplasmin in a family from central Slovakia]","volume":"101","author":"Zarnovicanova","year":"2000","journal-title":"Bratisl Lek Listy"},{"key":"10.1111\/jth.14160_bb0130","first-page":"483","article-title":"[Hemorrhagic syndrome and isolated alpha 2\u2010antiplasmin deficiency. Apropos of a case]","volume":"45","author":"Guermazi","year":"1997","journal-title":"Pathologie\u2010biologie"},{"key":"10.1111\/jth.14160_bb0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI109387","article-title":"Congenital deficiency of alpha 2\u2010plasmin inhibitor associated with severe hemorrhagic tendency","volume":"63","author":"Aoki","year":"1979","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14160_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1538-7836.2005.01114.x","article-title":"Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency","volume":"3","author":"Hayward","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0145","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.V59.6.1169.1169","article-title":"A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2\u2010antiplasmin","volume":"59","author":"Kluft","year":"1982","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2516.2007.01588.x","article-title":"A novel mutation of alpha2\u2010plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency","volume":"14","author":"Maino","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2516.2004.00914.x","article-title":"Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2\u2010plasmin inhibitor or plasminogen activator inhibitor\u20101","volume":"10","author":"Morimoto","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0049-3848(85)90302-0","article-title":"Severe hemorrhagic tendency in heterozygous alpha 2\u2010antiplasmin deficiency","volume":"40","author":"Kordich","year":"1985","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-3848(96)00059-X","article-title":"Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age","volume":"82","author":"Ikematsu","year":"1996","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00001721-200301000-00019","article-title":"A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency","volume":"14","author":"Hanss","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0175","doi-asserted-by":"crossref","first-page":"698648","DOI":"10.1155\/2011\/698648","article-title":"Antiplasmin deficiency complicating pregnancy: a case report","volume":"2011","author":"Dawley","year":"2011","journal-title":"Obstet Gynecol Int"},{"key":"10.1111\/jth.14160_bb0180","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1378\/chest.97.6.1488","article-title":"Open\u2010heart surgery in a patient with heterozygous alpha 2\u2010antiplasmin deficiency. Perioperative strategies in the first reported case","volume":"97","author":"Shahian","year":"1990","journal-title":"Chest"},{"key":"10.1111\/jth.14160_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0038-1646773","article-title":"Mild haemostatic problems associated with congenital heterozygous alpha 2\u2010antiplasmin deficiency","volume":"59","author":"Leebeek","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(83)90462-0","article-title":"Hereditary \u03b12\u2010antiplasmin deficiency","volume":"31","author":"Stormorken","year":"1983","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0195","first-page":"328","article-title":"Alpha 2\u2010antiplasmin deficiency. An overlooked cause of hemorrhage","volume":"15","author":"Griffin","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1111\/jth.14160_bb0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-0038-1661567","article-title":"Alpha 2\u2010antiplasmin: functional characterization and metabolism in a heterozygote deficient patient","volume":"55","author":"Knot","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2008.01894.x","article-title":"Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent","volume":"15","author":"Vijapurkar","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0210","first-page":"93","article-title":"[A congenital alpha2\u2010antiplasmin deficiency]","volume":"71","author":"Igala","year":"2013","journal-title":"Ann Biol Clin"},{"key":"10.1111\/jth.14160_bb0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2141.1999.01708.x","article-title":"A novel missense mutation in the human plasmin inhibitor (alpha2\u2010antiplasmin) gene associated with a bleeding tendency","volume":"107","author":"Lind","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0220","first-page":"294","article-title":"23 Heterozygote patients with \u03b12\u2010antiplasmin (\u03b12\u2010AP) Deficiency in 4 Dutch families","volume":"1","author":"Stibbe","year":"1986","journal-title":"Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0225","first-page":"457","article-title":"[Blind spots of the diagnostic hemostasis screen]","volume":"144","author":"Levi","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/jth.14160_bb0230","first-page":"273","article-title":"Severe bleeding in heterozygous alpha2\u2010plasmin inhibitor deficiency","volume":"26","author":"Cucuianu","year":"1989","journal-title":"Rev Roum Biochim"},{"key":"10.1111\/jth.14160_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajh.2830450104","article-title":"Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2\u2010plasmin inhibitor deficiency","volume":"45","author":"Okajima","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14160_bb0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.thromres.2004.01.001","article-title":"A new euglobulin clot lysis assay for global fibrinolysis","volume":"112","author":"Smith","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/vox.12395","article-title":"Increased coagulation and fibrinolytic potential of solvent\u2010detergent plasma: a comparative study between Omniplasma and fresh frozen plasma","volume":"111","author":"van Beers","year":"2016","journal-title":"Vox Sang"},{"key":"10.1111\/jth.14160_bb0250","doi-asserted-by":"crossref","first-page":"858293","DOI":"10.1155\/2014\/858293","article-title":"Functional stability of plasminogen activator inhibitor\u20101","volume":"2014","author":"Yasar Yildiz","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1111\/jth.14160_bb0255","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","article-title":"PAI\u20101, progress in understanding the clinical problem and its aetiology","volume":"157","author":"Iwaki","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood.V77.3.528.528","article-title":"A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1","volume":"77","author":"Dieval","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0270","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI114076","article-title":"Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor","volume":"83","author":"Schleef","year":"1989","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14160_bb0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hae.12313","article-title":"The obstetric, gynaecological and fertility implications of homozygous PAI\u20101 deficiency: single\u2010centre experience","volume":"20","author":"Heiman","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0280","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1538-7836.2007.02585.x","article-title":"What is the clinical impact of low plasminogen activator inhibitor\u20101 (PAI\u20101) activity? A case report and study of the incidence of low PAI\u20101 antigen in a healthy population","volume":"5","author":"Santamaria","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1538-7836.2005.01709.x","article-title":"Evaluation of low PAI\u20101 activity as a risk factor for hemorrhagic diathesis","volume":"4","author":"Agren","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0290","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199212103272406","article-title":"Brief report: complete deficiency of plasminogen\u2010activator inhibitor type 1 due to a frame\u2010shift mutation","volume":"327","author":"Fay","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14160_bb0295","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood.V81.9.2357.2357","article-title":"Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding","volume":"81","author":"Lee","year":"1993","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V90.1.204.204_204_208","article-title":"Human plasminogen activator inhibitor\u20101 (PAI\u20101) deficiency: characterization of a large kindred with a null mutation in the PAI\u20101 gene","volume":"90","author":"Fay","year":"1997","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0305","first-page":"286","article-title":"Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor\u20101 deficiency","volume":"29","author":"Minowa","year":"1999","journal-title":"Haemostasis"},{"key":"10.1111\/jth.14160_bb0310","first-page":"106","article-title":"Successful arthroscopic treatment of pigmented villonodular synovitis of the knee in a patient with congenital deficiency of plasminogen activator inhibitor\u20101 and recurrent haemarthrosis","volume":"31","author":"Matsui","year":"2001","journal-title":"Haemostasis"},{"key":"10.1111\/jth.14160_bb0315","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00417-005-0048-x","article-title":"Massive subhyaloidal hemorrhage associated with severe PAI\u20101 deficiency","volume":"243","author":"Kuhli","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/jth.14160_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001721-200501000-00013","article-title":"A case of deficiency of plasma plasminogen activator inhibitor\u20101 related to Ala15Thr mutation in its signal peptide","volume":"16","author":"Zhang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0325","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/etm_00000090","article-title":"Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1","volume":"1","author":"Jankun","year":"2010","journal-title":"Exp Ther Med"},{"key":"10.1111\/jth.14160_bb0330","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/SMJ.0b013e3181faee7e","article-title":"Pregnancy complicated by plasminogen activator inhibitor type 1 deficiency","volume":"103","author":"Smith","year":"2010","journal-title":"South Med J"},{"key":"10.1111\/jth.14160_bb0335","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1538-7836.2011.04288.x","article-title":"Life\u2010threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor\u20101 deficiency in humans","volume":"9","author":"Iwaki","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0340","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.thromres.2011.10.008","article-title":"The first report of uncontrollable subchorionic and retroplacental haemorrhage inducing preterm labour in complete PAI\u20101 deficiency in a human","volume":"129","author":"Iwaki","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14160_bb0345","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MBC.0000000000000254","article-title":"Plasminogen activator inhibitor type 1 deficiency revealed by severe bleeding after prostatectomy in a 76\u2010year\u2010old male","volume":"26","author":"Bauduer","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0350","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/hae.12929","article-title":"Total hip arthroplasty and total knee arthroplasty in a patient with congenital deficiency of plasminogen activator inhibitor\u20101","volume":"22","author":"Hirose","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14160_bb0355","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/107602960401000316","article-title":"Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor\u20101: case report and literature review","volume":"10","author":"Repine","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.14160_bb0360","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajh.2830380314","article-title":"Increased levels of tissue plasminogen activator with a low plasminogen activator inhibitor\u20101 in a patient with postoperative bleeding","volume":"38","author":"Stankiewicz","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14160_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0925-5710(96)00460-4","article-title":"Hereditary partial deficiency of plasminogen activator inhibitor\u20101 associated with a lifelong bleeding tendency","volume":"64","author":"Takahashi","year":"1996","journal-title":"Int J Hematol"},{"key":"10.1111\/jth.14160_bb0370","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1160\/TH16-07-0572","article-title":"Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation","volume":"117","author":"Iwaki","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0375","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00431-005-1683-2","article-title":"Bleeding diathesis in a child with normal screening tests: think about fibrinolysis","volume":"164","author":"Largent","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1111\/jth.14160_bb0380","doi-asserted-by":"crossref","first-page":"E1192","DOI":"10.1227\/01.NEU.0000345650.60160.07","article-title":"A novel association between a chronic subdural hematoma and a fibrinolytic pathway defect: case report","volume":"64","author":"Rughani","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1111\/jth.14160_bb0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archneurol.2009.319","article-title":"Intraparenchymal hemorrhage in a patient with osteogenesis imperfecta and plasminogen activator inhibitor\u20101 deficiency","volume":"67","author":"Goddeau","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1111\/jth.14160_bb0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jvir.2006.10.015","article-title":"Uterine artery embolization for control of life\u2010threatening hemorrhage at menarche: brief report","volume":"18","author":"Bowkley","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/jth.14160_bb0395","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nm.3552","article-title":"PAI\u20101 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin","volume":"20","author":"Bajou","year":"2014","journal-title":"Nat Med"},{"key":"10.1111\/jth.14160_bb0400","first-page":"1068","article-title":"The case of a late bleeder plasminogen activator inhibitor 1 deficiency","volume":"2","author":"Del Rosario","year":"2015","journal-title":"Ann Hematolo Oncol"},{"key":"10.1111\/jth.14160_bb0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.CIR.79.1.101","article-title":"Diurnal variation of tissue\u2010type plasminogen activator and its rapid inhibitor (PAI\u20101)","volume":"79","author":"Angleton","year":"1989","journal-title":"Circulation"},{"key":"10.1111\/jth.14160_bb0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/ehm.11.5","article-title":"Quebec platelet disorder","volume":"4","author":"Hayward","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1111\/jth.14160_bb0415","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2003-11-4077","article-title":"Bleeding risks associated with inheritance of the Quebec platelet disorder","volume":"104","author":"McKay","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0420","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V98.2.257","article-title":"Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase\u2010type plasminogen activator","volume":"98","author":"Kahr","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0425","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood-2008-08-175216","article-title":"Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes","volume":"113","author":"Diamandis","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0430","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI111531","article-title":"Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency","volume":"74","author":"Tracy","year":"1984","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14160_bb0435","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0031-1291382","article-title":"Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment","volume":"37","author":"Blavignac","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14160_bb0440","first-page":"549","article-title":"Quebec platelet disorder","volume":"20","author":"Abbasi","year":"2010","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1111\/jth.14160_bb0445","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1182\/blood.V87.12.4967.bloodjournal87124967","article-title":"An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect","volume":"87","author":"Hayward","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0450","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MBC.0b013e328304e099","article-title":"Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coag Fibrinol"},{"key":"10.1111\/jth.14160_bb0455","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MBC.0b013e3282f41e3e","article-title":"Quebec platelet disorder: features, pathogenesis and treatment","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0460","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood-2009-07-233965","article-title":"Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene","volume":"115","author":"Paterson","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V61.2.267.267","article-title":"A new life\u2010long hemorrhagic disorder due to excess plasminogen activator","volume":"61","author":"Booth","year":"1983","journal-title":"Blood"},{"key":"10.1111\/jth.14160_bb0470","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0038-1661171","article-title":"Inherited fibrinolytic disorder due to an enhanced plasminogen activator level","volume":"52","author":"Aznar","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0475","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/102.6.816","article-title":"Life\u2010long bleeding diathesis: effect of orthotopic liver transplantation","volume":"102","author":"Humphries","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.14160_bb0480","first-page":"42A","article-title":"Plasma activator of plasminogen: cause of a familial bleeding diathesis","volume":"51","author":"Hampton","year":"1972","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14160_bb0485","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2141.2000.01890.x","article-title":"Reduced activity of TAFI (thrombin\u2010activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia","volume":"108","author":"Meijers","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0490","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","article-title":"The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u\u2010PA rather than defibrination","volume":"71","author":"Bennett","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14160_bb0495","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","article-title":"Annexin II and bleeding in acute promyelocytic leukemia","volume":"340","author":"Menell","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14160_bb0500","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0035-1550437","article-title":"The fibrinolytic status in liver diseases","volume":"41","author":"Leebeek","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14160_bb0505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/rth2.12028","article-title":"Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases","volume":"1","author":"Lisman","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0510","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0002-9343(85)90321-3","article-title":"Fibrinolysis and acquired alpha\u20102 plasmin inhibitor deficiency in amyloidosis","volume":"79","author":"Meyer","year":"1985","journal-title":"Am J Med"},{"key":"10.1111\/jth.14160_bb0515","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00001721-199804000-00010","article-title":"Hyperfibrinogenolysis in disseminated adenocarcinoma","volume":"9","author":"Meijer","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14160_bb0520","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.282.6270.1121","article-title":"Acquired alpha 2 antiplasmin deficiency in glomerular proteinuria","volume":"282","author":"Taberner","year":"1981","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1111\/jth.14160_bb0525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14160_bb0530","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11239-007-0187-5","article-title":"Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass","volume":"27","author":"Yavari","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.14160_bb0535","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2042098615572333","article-title":"Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem","volume":"6","author":"Daley","year":"2015","journal-title":"Ther Adv Drug Saf"},{"key":"10.1111\/jth.14160_bb0540","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke"},{"key":"10.1111\/jth.14160_bb0545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2253-12-27","article-title":"PAI\u20101 and t\u2010PA\/PAI\u20101 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass","volume":"12","author":"Ozolina","year":"2012","journal-title":"BMC Anesthesiology."},{"key":"10.1111\/jth.14160_bb0550","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"van Geffen","year":"2011","journal-title":"Hematology"},{"key":"10.1111\/jth.14160_bb0555","first-page":"178","article-title":"Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis","volume":"43","author":"Lisman","year":"2017","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622022073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622022073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14160\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:22:25Z","timestamp":1761535345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622022073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1538783622022073"],"URL":"https:\/\/doi.org\/10.1111\/jth.14160","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemorrhagic disorders of fibrinolysis: a clinical review","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Authors. Journal of Thrombosis and Haemostasis. Published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}